Urology Market – Understated Needs
Passing urine is (hopefully) a very normal every day occurrence. But for many people, urological disease can dramatically reduce quality of life and cause significant suffering.
The conditions that feed the urological devices market are numerous. Benign prostatic hyperplasia (BPH) is the precursor to prostate cancer, and affects thousands of men, giving them difficulty in passing urine. The opposite – incontinence – can have many causes. Damage to muscles, nerves or simply old age can cause incontinence.
The solutions for these and many other urological conditions is catheters, implants and other invasive therapies such as brachytherapy and cryotherapy. In total, this market in Europe alone is worth over $1.06 billion. As more people live for longer with prostate cancer and our population ages, these issues are going to become more prominent. Also, patients are becoming more empowered, as the stigma around urological conditions is reduced. People are now seeking treatment earlier, before symptoms become unbearable, when there are more options. This report on the BioPortfolio report store, European Markets for Urological Devices, details the market breakdown and specifics.